Medinova Diagnostic Services Limited

BSE:526301 Stok Raporu

Piyasa değeri: ₹381.2m

Medinova Diagnostic Services Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Medinova Diagnostic Services has been growing earnings at an average annual rate of 16.8%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 1.8% per year.

Anahtar bilgiler

16.8%

Kazanç büyüme oranı

17.0%

EPS büyüme oranı

Healthcare Sektör Büyümesi29.4%
Gelir büyüme oranı1.8%
Özkaynak getirisin/a
Net Marj19.4%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Medinova Diagnostic Services nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BSE:526301 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24991960
30 Jun 241022100
31 Mar 241022060
31 Dec 231042250
30 Sep 231032050
30 Jun 23991700
31 Mar 231001750
31 Dec 22991220
30 Sep 221031420
30 Jun 221111520
31 Mar 221322320
31 Dec 211332520
30 Sep 211443020
30 Jun 211573120
31 Mar 211272020
31 Dec 201191620
30 Sep 2099720
30 Jun 2071-200
31 Mar 2074-320
31 Dec 19791030
30 Sep 1981730
30 Jun 1988900
31 Mar 1990830
31 Dec 1890460
30 Sep 1893460
30 Jun 1890300
31 Mar 1887-560
31 Dec 1784-650
30 Sep 1782-1350
30 Jun 1780-1550
31 Mar 1778-1780
31 Dec 1690-2760
30 Sep 1693-2560
30 Jun 1691-2000
31 Mar 1681-1960
31 Dec 1572-3860
30 Sep 1567-3360
30 Jun 1570-3660
31 Mar 1577-3660
31 Dec 1483-94512
30 Sep 1494-74512
30 Jun 14101-300
31 Mar 1411104512
31 Dec 13123-25012

Kaliteli Kazançlar: 526301 has high quality earnings.

Büyüyen Kar Marjı: 526301's current net profit margins (19.4%) are lower than last year (19.5%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 526301's earnings have grown by 16.8% per year over the past 5 years.

Büyüme Hızlandırma: 526301's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 526301 had negative earnings growth (-4.1%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).


Özkaynak Getirisi

Yüksek ROE: 526301's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin